Current filters:


Popular Filters

8020 to 8044 of 8448 results

Watson to invest $44 million in R&D and manufacturing plant expansion


US branded and generics drugmaker Watson Pharmaceuticals (NYSE: WPI) says it is investing around $44…

FinancialGenericsLidodermNeurologicalPfizerWatson Pharmaceuticals

Jubilant and AstraZeneca successful in delivery of early milestones in pain drug accord


Jubilant Biosys, a Bengaluru-based subsidiary of India’s Jubilant Life Sciences, and Anglo-Swedish…


India tells UN meeting it will not accept data exclusivity as part of FTA with EU


India formally announced at the UN High Level Meeting on HIV and AIDS held in New York, USA, earlier…


CSL Biotherapies gets official warning letter from US FDA


The US Food and Drug Administration issued a formal warning letter to Australia’s largest biotech…

AfluriaAsia-PacificBiotechnologyCSL BiotherapiesCSL LimitedNorth AmericaRegulationVaccines

Merck KGaA drops plans for oral MS drug cladribine, leaving field clear for Gilenya


German drug major Merck KGaA (MRK: DE) said yesterday that, following feedback from regulatory authorities,…

CladribineGilenyaMarkets & MarketingMerck KGaANeurologicalNovartisPharmaceuticalRegulation

EU clears anti-JC virus risk labeling for Biogen and Elan’s Tysabri


US biotech firm Biogen Idec (Nasdaq: BIIB) and Ireland-based Elan (NYSE: ELN) said yesterday that the…

Biogen IdecBiotechnologyElanEuropeNeurologicalRegulationTysabri

Johnson & Johnson invests $30 million in deal with Russia’s Skolkovo


US health care giant Johnson & Johnson (NYSE: JNJ), together with its pharmaceutical division Janssen…

Anti-viralsEuropeFinancialJanssen PharmaceuticaJohnson & JohnsonOncologyPharmaceuticalResearch

Roche to start production of Herceptin in Russia


R-Farm, one of Russia’s largest drugs’ distributors, has reached an agreement with Roche (ROG:…

EuropeHerceptinLicensingMarkets & MarketingOncologyPharmaceuticalR-FarmRoche

US FDA approves ProStrakan’s Rectiv for anal fissures pain


Scotland-based ProStrakan, now a subsidiary of Japan’s Kyowa Hakko Kirin (TYO: 4151) as the result…

Gastro-intestinalsKyowa Hakko KirinNorth AmericaPharmaceuticalProStrakanRectivRectogesicRegulation

EU generic drugmakers launch code of conduct on MAA slots


The European Generic medicines Association (EGA) says it has officially launched a code of conduct on…


Canada’s PMPRB reports slow-down in pharma sales


In its annual report for 2010 released to Canada’s Parliament last week, the Patented Medicine Prices…

GenericsMarkets & MarketingNorth AmericaPatentsPharmaceuticalPoliticsPricing

Eli Lilly gets EU approval for long-acting diabetes drug Bydureon


In what was excellent news for all three companies following rejections of the drug by US regulators,…

AlkermesAmylinBydureonDiabetesEli LillyEuropePharmaceuticalRegulation

Rise in M&A for China's pharmaceutical sector forecast by KPMG


Both multinationals drugmakers and large domestic players are set to grab a larger share of the pharmaceutical…

Asia-PacificGenericsHealthcareMergers & AcquisitionsPharmaceutical

Novo Nordisk invests $190 million in new Danish plant, AstraZeneca sells Astra Tech


Danish insulin giant Novo Nordisk (NVO: N) said this morning that it is investing close to 1 billion…

AstraZenecaFinancialMergers & AcquisitionsNovo NordiskPharmaceutical

Positive mid-stage data on Roche and Curis' BCC drug vismodegib


Swiss drug major Roche (ROG: SIX) yesterday reported positive results from a mid-stage trial on vismodegib…


Pfizer’s Lyrica meets endpoint in Ph III study of central neuropathic pain after spinal cord injury


Global drugs behemoth Pfizer (NYSE: PFE) says its blockbuster neuropathic pain drug Lyrica (pregabalin)…


US FDA views ways to improve consumer understanding of Rx drug ads


Findings from three studies conducted by the US Food and Drug Administration confirm that the way information…

Markets & MarketingNorth AmericaPharmaceuticalRegulation

Joint ventures in generics to boost Indian pharma industry


The Indian pharmaceutical industry is moving towards the adoption and development of generic drugs, which…

Asia-PacificGenericsMarkets & MarketingMergers & Acquisitions

Indonesia MoH and PFCD address challenges posed by chronic NCDs


The Indonesia Ministry of Health and the Partnership to Fight Chronic Disease (PFCD: a USA-based non-governmental…


Australia and New Zealand resurrect plans for joint Therapeutic Products Agency; Medicines Australia views impact


The governments of Australian and New Zealand have agreed to proceed with a joint scheme for regulation…


Pfizer and Acura’s tamper resistant opioid Oxecta gets US FDA approval


After a significant delay, drugs behemoth Pfizer (NYSE: PFE) and partner Acura Pharmaceuticals (Nasdaq:…

Acura PharmaceuticalsNeurologicalNorth AmericaOxectaPfizerPharmaceuticalRegulationRemoxy

8020 to 8044 of 8448 results

Back to top